Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracochlear Steroid Delivery in Complete Sudden Sensorineural Hearing Loss
NCT07540728Phase 2Not yet recruiting
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Apr 2026
- Primary completion
- Apr 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide, dexamethasone in sudden sensorineural hearing loss (SSHL), sponsored by Eye and ENT Hospital of Fudan University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
triamcinolone acetonidedexamethasone
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT07540728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07540728.